Compare SOTK & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOTK | DXR |
|---|---|---|
| Founded | 1975 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.0M | 59.0M |
| IPO Year | 1995 | 1995 |
| Metric | SOTK | DXR |
|---|---|---|
| Price | $4.25 | $8.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $8.50 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 105.0K | 11.1K |
| Earning Date | 10-14-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.50 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $20,909,315.00 | $1,446,345.00 |
| Revenue This Year | $2.67 | $44,489.33 |
| Revenue Next Year | $23.22 | $74.79 |
| P/E Ratio | $62.14 | ★ $33.83 |
| Revenue Growth | ★ 1.97 | N/A |
| 52 Week Low | $3.40 | $8.24 |
| 52 Week High | $7.48 | $14.76 |
| Indicator | SOTK | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 32.35 | 30.42 |
| Support Level | $4.25 | N/A |
| Resistance Level | $4.62 | $12.07 |
| Average True Range (ATR) | 0.28 | 0.34 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 11.03 | 19.79 |
Sono-Tek Corp designs and manufactures ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and emerging research & development/other markets. The company designs and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.